Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$21.6 - $27.79 $1.99 Million - $2.56 Million
92,100 Added 19.07%
575,100 $13.1 Million
Q4 2021

Feb 15, 2022

BUY
$23.0 - $29.01 $3.59 Million - $4.53 Million
156,100 Added 47.75%
483,000 $13.3 Million
Q3 2021

Nov 16, 2021

SELL
$25.04 - $30.06 $7.17 Million - $8.61 Million
-286,500 Reduced 46.71%
326,900 $9.1 Million
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $5.86 Million - $6.98 Million
213,600 Added 53.43%
613,400 $18 Million
Q1 2021

May 18, 2021

SELL
$21.37 - $34.38 $1.76 Million - $2.84 Million
-82,500 Reduced 17.11%
399,800 $12.7 Million
Q4 2020

Feb 17, 2021

SELL
$15.31 - $21.12 $2.27 Million - $3.14 Million
-148,500 Reduced 23.54%
482,300 $10 Million
Q3 2020

Nov 17, 2020

BUY
$14.88 - $20.13 $4.85 Million - $6.56 Million
326,100 Added 107.02%
630,800 $9.8 Million
Q2 2020

Aug 17, 2020

BUY
$13.31 - $20.51 $3.39 Million - $5.23 Million
254,800 Added 510.62%
304,700 $5.57 Million
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $497,134 - $1.16 Million
-38,300 Reduced 43.42%
49,900 $773,000
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $695,152 - $1.17 Million
36,800 Added 71.6%
88,200 $2.64 Million
Q3 2019

Nov 14, 2019

BUY
$20.88 - $25.66 $177,480 - $218,110
8,500 Added 19.81%
51,400 $1.12 Million
Q2 2019

Aug 15, 2019

SELL
$20.52 - $26.45 $1.58 Million - $2.04 Million
-77,000 Reduced 64.22%
42,900 $1.08 Million
Q1 2019

May 16, 2019

BUY
$20.23 - $26.29 $1.48 Million - $1.93 Million
73,400 Added 157.85%
119,900 $2.96 Million
Q4 2018

Feb 15, 2019

SELL
$17.64 - $28.32 $114,660 - $184,080
-6,500 Reduced 12.26%
46,500 $859,000
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $1.09 Million - $1.36 Million
53,000 New
53,000 $1.36 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.38B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.